HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of Bispecific Antibody Targeting EpCAM and CD3 for Immunotherapy in Ovarian Cancer Ascites: An Experimental Study.

AbstractOBJECTIVE:
This study aimed to explore the value of M701, targeting epithelial cell adhesion molecule (EpCAM) and CD3, in the immunotherapy of ovarian cancer ascites by the in vitro assay.
METHODS:
The expression of EpCAM in ovarian cancer tissues was analyzed by databases. The EpCAM expression and immune cell infiltration in different foci of ovarian cancer were detected by 8-channel flow cytometry. The toxic effect of M701 on OVCAR3 was tested using the in vitro cytotoxicity assay. The 3D cell culture and drug intervention experiments were performed to evaluate the therapeutic effect of M701 in ovarian cancer specimens. Flow cytometry was used to examine the effect of M701 on the binding of immune cells to tumor cells and the activation capacity of T cells.
RESULTS:
The results of the bioinformatic analysis showed that the expression of EpCAM in ovarian cancer tissue was significantly higher than that in normal ovarian tissue. The 8-channel flow cytometry of clinical samples showed that the EpCAM expression and lymphocyte infiltration were significantly heterogeneous among ovarian cancer patients and lesions at different sites. The in vitro experiment results showed that M701 had a significant killing effect on OVCAR3 cells. M701 also obviously killed primary tumor cells derived from some patients with ovarian cancer ascites. M701 could mediate the binding of CD3+ T cells to EpCAM+ tumor cells and induce T cell activation in a dose-dependent manner.
CONCLUSION:
M701 showed significant inhibitory activity on tumor cells derived from ovarian cancer ascites, which had a promising application in immunotherapy for patients with ovarian cancer ascites.
AuthorsYi-Nuo Li, Yuan-Yuan Li, Shi-Xuan Wang, Xiang-Yi Ma
JournalCurrent medical science (Curr Med Sci) Vol. 43 Issue 3 Pg. 539-550 (Jun 2023) ISSN: 2523-899X [Electronic] China
PMID37119369 (Publication Type: Journal Article)
Copyright© 2023. Huazhong University of Science and Technology.
Chemical References
  • Epithelial Cell Adhesion Molecule
  • Cell Adhesion Molecules
  • Antigens, Neoplasm
  • Antibodies, Bispecific
Topics
  • Female
  • Humans
  • Epithelial Cell Adhesion Molecule (genetics, therapeutic use)
  • Ovarian Neoplasms (drug therapy)
  • Ascites
  • Cell Adhesion Molecules (genetics)
  • Antigens, Neoplasm
  • Apoptosis
  • Cell Line, Tumor
  • Antibodies, Bispecific (pharmacology)
  • Immunotherapy (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: